Technology
Health
Pharmaceutical

IDEAYA Biosciences

$6.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.32 (-4.57%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell IDYA and other stocks, options, ETFs, and crypto commission-free!

About IDYA

IDEAYA Biosciences, Inc. Common Stock, also called IDEAYA Biosciences, is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Read More The company operates and manages its business as one operating and reportable segment, which is the business of research and development for oncology-focused precision medicine. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Employees
58
Headquarters
South San Francisco, California
Founded
2015
Market Cap
135.66M
Price-Earnings Ratio
Dividend Yield
Average Volume
8.99K
High Today
$6.94
Low Today
$6.70
Open Price
$6.94
Volume
3.52K
52 Week High
$16.90
52 Week Low
$6.55

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
Cancer Prevention
Research And Development
2019 IPO

IDYA Earnings

-$1.56
-$1.39
-$1.21
-$1.04
Q2 2019
Estimated
Actual
-$1.30 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.